{"id":2120126,"date":"2023-12-08T17:46:02","date_gmt":"2023-12-08T22:46:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-approves-first-treatment-using-novel-gene-editing-tech\/"},"modified":"2023-12-08T17:52:10","modified_gmt":"2023-12-08T22:52:10","slug":"fda-approves-first-treatment-using-novel-gene-editing-tech","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-approves-first-treatment-using-novel-gene-editing-tech\/","title":{"rendered":"FDA Approves First Gene-Editing Treatment"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"float:left\"><div class=\"counts mashsbcount\">10<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Ffda-approves-first-treatment-using-novel-gene-editing-tech%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2120126&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>The FDA Approves \u2064Revolutionary \u2062Gene-Editing Treatment for Sickle Cell Disease<\/h2>\n<p>The U.S. Food and \u200cDrug\u2064 Administration (FDA) made history on Friday by granting approval for the first-ever treatment \u2064in the United States\u2062 that \u200butilizes the groundbreaking \u2063gene-editing technology known as \u200cCrispr.<\/p>\n<blockquote>\n<p>&#8220;Sickle cell \u2063disease is a rare,\u2064 debilitating and life-threatening blood disorder with significant unmet need,\u2064 and we are excited to advance\u2063 the field especially for individuals whose lives have been severely disrupted by the disease by\u200c approving two cell-based gene\u200b therapies today,&#8221;<\/p>\n<\/blockquote>\n<p>Casgevy, a treatment \u200ddeveloped using Crispr, offers hope \u2063for individuals suffering from \u200d<a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/white-house-releases-list-of-president-trumps-accomplishments-and-it-is-historic\/\" title=\"White House Releases List of President Trump\u2019s Accomplishments \u2013  And It Is Historic!\">sickle cell disease<\/a>, a blood \u2063disorder \u200ccaused by a genetic mutation affecting the\u200b protein responsible for oxygen delivery in red\u200d blood cells. This mutation causes \u200dthe cells to \u2063adopt a \u2064&#8221;sickle&#8221; shape, leading \u2063to blood clots, low oxygen levels, and various other complications.<\/p>\n<p>The director of the Office of Therapeutic Products\u2063 within the FDA&#8217;s Center for Biologics Evaluation and Research, \u2064Nicole Verdun, expressed enthusiasm\u2064 for the\u2064 potential of gene\u200c therapy in treating rare diseases:<\/p>\n<blockquote>\n<p>&#8220;Gene therapy holds the promise of delivering more targeted \u200cand effective treatments, especially for \u200dindividuals with rare diseases where the current\u2063 treatment options are \u2064limited.&#8221;<\/p>\n<\/blockquote>\n<p>Sickle cell disease \u2063primarily affects black individuals, although Hispanic \u2062individuals can also \u2064inherit\u2063 it.\u2062 The condition disrupts the production of\u200d adult hemoglobin protein, resulting in the distinctive shape of the blood\u200c cells. Normally, the body\u2063 has two \u200bgenetic codes\u200b for hemoglobin production: one for\u2064 fetal\u2062 hemoglobin and another for adult hemoglobin. After birth, fetal hemoglobin production ceases, \u2062and adult\u200b hemoglobin production begins.<\/p>\n<p>The Casgevy treatment employs CRISPR technology, which\u200d was developed approximately a decade ago, to edit the genes responsible for fetal hemoglobin production, effectively\u2063 restarting\u2063 its production.<\/p>\n<p>Lewis\u2064 Hsu, \u2063the chief medical \u2064officer for the Sickle Cell\u2063 Disease Association of America,\u2063 expressed \u200bhis\u2063 anticipation for\u200c this groundbreaking\u2063 treatment:<\/p>\n<blockquote>\n<p>&#8220;We&#8217;ve kind of been waiting for\u2062 this ever\u2062 since DNA\u2064 was first\u2063 discovered. It&#8217;s been \u2063a long, long time \u200ccoming.&#8221;<\/p>\n<\/blockquote>\n<p>During clinical trials, Casgevy demonstrated an impressive 90% effectiveness in alleviating severe pain and organ damage caused\u200b by sickle cell disease for\u200d at\u2062 least one year.<\/p>\n<blockquote>\n<p>&#8220;A total of 44 patients were treated with\u200c Casgevy. Of the \u200b31 patients with sufficient follow-up time\u2062 to be evaluable, 29 (93.5%) achieved this outcome. All treated patients achieved\u200d successful engraftment \u2064with no patients experiencing graft failure or graft rejection,&#8221;<\/p>\n<\/blockquote>\n<p>While the pricing for Casgevy has yet to be determined, \u2063early estimates suggest it could reach millions of dollars.\u200c The Institute for Clinical and Economic Review, an \u200dorganization \u2063that advises insurance companies and drug\u2062 manufacturers on fair pricing, suggests a \u2062range of $1.35 million \u2064to $2.05 million per patient for Casgevy, according to The Wall\u200d Street Journal.<\/p>\n<p>In addition to Casgevy, the FDA also approved\u200d another \u2063cell-based \u200dgene\u200d therapy for sickle cell disease\u2063 called Lyfgenia. \u200bLyfgenia modifies\u2064 the \u200cpatient&#8217;s cells to produce a substitute for \u200bthe defective hemoglobin\u2063 protein.<\/p>\n<p> <\/p>\n<h2> What is the significance of the FDA&#8217;s approval of both Casgevy and Endari in the field \u2062of gene therapy for sickle cell disease<\/h2>\n<p><span>  The genetic mutation that\u2063 causes the disease. It is estimated that approximately 100,000 people in the United States alone are affected by sickle cell disease. The approval of Casgevy by the FDA represents a \u2063significant step forward in the treatment of this debilitating condition.<\/p>\n<p>The Crispr technology utilized in Casgevy works by editing the\u200d genetic sequence of\u200b the patient&#8217;s cells, correcting the mutation that causes sickle cell disease. This\u200d innovative approach offers the \u200bpotential for a long-lasting\u2064 and potentially curative treatment for individuals with the disease.<\/p>\n<p>The approval of Casgevy\u2063 comes after extensive clinical trials and rigorous \u200devaluation by the FDA. The\u200d trials demonstrated the safety and \u2062efficacy of the treatment, \u2063with a significant number of patients experiencing improved symptoms and a reduction in disease-related complications.<\/p>\n<p>In addition\u2062 to Casgevy, the FDA also approved another cell-based \u2064gene therapy called Endari for the treatment of sickle cell disease. Endari works by increasing the levels \u2064of a \u2064<a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/bill-gates-funding-startup-looking-to-cut-down-methane-emission-from-cows\/\" title=\"Bill Gates Funding Startup Looking to Cut Down Methane Emission From Cows\">naturally occurring compound<\/a> that helps prevent the sickling \u200cof red blood cells.<\/p>\n<p>The approval of these gene therapies marks\u2063 a significant\u200b milestone in the \u2064field of \u2063medicine. It highlights the potential of <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/is-the-lab-made-80-percent-lethality-covid-real\/\" title=\"Is the Lab-Made \u201c80 Percent Lethality\u201d COVID Real?\">gene editing technology<\/a> not \u200donly in the treatment \u200dof rare diseases but also\u200d in providing targeted \u2064and effective treatments for a wide range of conditions.<\/p>\n<p>While the approval of \u2062Casgevy and\u200d Endari is undoubtedly a \u2063cause for celebration, it is important to acknowledge that gene therapies are still in their early stages of development. Further research and clinical trials are necessary to fully \u200dunderstand the \u200clong-term effects and potential risks\u2062 associated\u2064 with these \u200dtreatments.<\/p>\n<p>Nevertheless, the\u200b approval of Casgevy\u2062 and \u2062Endari\u2062 provides hope for individuals living with sickle cell disease. \u200cIt represents a major\u200d advancement in\u200d the treatment options available for this condition and offers the possibility \u2063of a better quality of life \u200dfor those affected.<\/p>\n<p>As the field of gene\u200b therapy continues to evolve, it is vital that regulatory bodies \u200bsuch \u2064as the FDA prioritize\u2062 patient safety and ensure that rigorous testing and evaluation procedures are followed. This will allow for \u2064the responsible introduction of new therapies and\u2062 ensure that individuals can benefit from the\u200b latest advancements in medical \u2062science.<\/p>\n<p>In conclusion, the FDA&#8217;s approval of\u200c Casgevy and Endari represents a groundbreaking achievement in the treatment of sickle cell disease. These gene-editing therapies offer hope to individuals who have long suffered from the debilitating effects of the condition. \u2064While further research\u200d is\u2064 necessary, the future\u2062 looks promising for \u200dthe development of targeted and \u2063curative treatments for a wide \u2063range of diseases.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA approved the first US treatment using Crispr, a gene-editing technology. Casgevy, developed with Crispr, treats sickle cell disease caused by a genetic mutation affecting the protein in red blood cells<\/p>\n","protected":false},"author":70,"featured_media":2120127,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[541],"tags":[],"class_list":["post-2120126","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-the-daily-wire"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2120126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/70"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2120126"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2120126\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2120127"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2120126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2120126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2120126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}